SMMT - Summit Therapeutics plc

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Jan 2018)Next Qtr. (Apr 2018)Current Year (2018)Next Year (2019)
No. of Analysts4444
Avg. Estimate-0.42-0.33-0.36-0.92
Low Estimate-0.79-0.68-0.78-1.58
High Estimate-0.1-0.05-0.04-0.21
Year Ago EPS-0.45-0.5-2.2-0.36
Revenue EstimateCurrent Qtr. (Jan 2018)Next Qtr. (Apr 2018)Current Year (2018)Next Year (2019)
No. of Analysts7667
Avg. Estimate4.29M3.58M36.05M18.12M
Low Estimate2.1M2.1M31.8M5M
High Estimate10.33M9.11M43.94M43.25M
Year Ago Sales2.17M2.24M2.9M36.05M
Sales Growth (year/est)97.20%60.10%1,143.50%-49.70%
Earnings History10/30/20161/30/20177/30/201710/30/2017
EPS Est.3.01-0.480.35-0.58
EPS Actual-0.45-0.51.1-0.2
Difference-3.46-0.020.750.38
Surprise %-115.00%-4.20%214.30%65.50%
EPS TrendCurrent Qtr. (Jan 2018)Next Qtr. (Apr 2018)Current Year (2018)Next Year (2019)
Current Estimate-0.42-0.33-0.36-0.92
7 Days Ago-0.42-0.33-0.36-0.92
30 Days Ago-0.42-0.33-0.36-0.92
60 Days Ago-0.35-0.34-0.44-1.13
90 Days Ago-0.22-0.1-0.6-0.73
EPS RevisionsCurrent Qtr. (Jan 2018)Next Qtr. (Apr 2018)Current Year (2018)Next Year (2019)
Up Last 7 DaysN/A11N/A
Up Last 30 DaysN/A11N/A
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesSMMTIndustrySectorS&P 500
Current Qtr.6.70%N/AN/A0.42
Next Qtr.34.00%N/AN/A0.38
Current Year83.60%N/AN/A0.20
Next Year-155.60%N/AN/A0.10
Next 5 Years (per annum)N/AN/AN/A0.12
Past 5 Years (per annum)N/AN/AN/AN/A